Abstract
Acute lung injury is a topic of great interest in critical care medicine due to
its high mortality rates. The lungs are the immediate target organ for formaldehyde
inhalation damage. Lung damage and fibrosis are the most important outcomes of
severe and acute lung disease and pose a serious threat to human health. Melatonin
(MT), a natural bioactive compound with anti-inflammatory and antioxidant
properties, However, it is not clear whether MT can prevent FA-induced acute lung
injury (ALI). Therefore, in this study, we aimed to evaluate the protective effects of
MT and the potential mechanisms against FA-induced ALI. An environmental
exposure bin was used to inhale 3 mg∙m3 FA-induced ALI, which was given
intraperitoneally with different doses of MT (5/10/20 mg/kg) after successful
modeling. In addition, rats were treated with Nrf2 inhibitor (ML385) to validate the
signaling pathway. Lung function was measured, histopathological/morphological
changes in lung tissue were assessed, and inflammatory expression and oxidation
levels in lung tissue were detected. We observed that MT greatly alleviated the lung
dysfunction, pathological lung injury, pulmonary edema and inflammatory response
after successful modeling of FA. In additional, MT played a role in modulating the
Nrf2/HO-1 signaling pathway, which effectively inhibit oxidative stress caused by
FA-induced lung tissue injure. Moreover, we found that activation of the NF-κB
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
pathway is associated with inflammation caused by this injury. Overall, our data
suggest that MT inhibits the expression of oxidative stress and inflammation in lung
tissue through the institutional or Nrf2/HO-1 pathway, alleviating FA-induced ALI.
1. Introduction
Acute lung injury (ALI) is an early lesion of ARDS, ALI and more severe ARDS
as common mortality and life-threatening lung diseases. Although some progress has
been made in the diagnosis and treatment of ALI/ARDS, the pathogenesis is very
complex due to its many causative factors.1 There are still no effective therapeutic
measures, which allows the mortality rate of the disease to remain as high as 40% and
seriously affects the prognosis of critically ill patients.2 The protein-rich edematous
fluid in ALI/ARDS is associated with large numbers of neutrophils, pro-inflammatory
cytokines and cytokines, proteases and oxidants.3
Formaldehyde (FA) is widely used in modern industry and is a widespread
environmental and occupational pollutant, and among all known health effects of FA,
lung injury is one of the most serious risks. Millions of people worldwide are exposed
to FA every day.4 Studies have shown that FA leads to ALI through reduced
transalveolar Na+ transport, reduced human epithelial sodium channel activity and
enhanced membrane depolarization, and increased ROS production.5-6 ROS
upregulate inflammatory cytokines and perpetuate malignancy by recruiting more
inflammatory cells to perpetuate the vicious cycle, ultimately leading to severe tissue
damage.7 Addressing inflammation and oxidative stress, which can lead to lung injury,
is a desirable goal in the treatment of FA-induced ALI. Currently, there are no
effective therapeutic agents and preventive strategies in clinical practice. And
multiple drug candidates with novel and unique mechanisms of action are needed.
Melatonin (MT) has been reported to play a key role in various physiological
activities, including the regulation of circadian rhythms, immune responses, oxidative
processes, apoptosis or mitochondrial homeostasis,8 and its most prominent
pharmacological effects are the scavenging of free radicals and the inhibition of
inflammatory responses.9 Recent studies have shown that MT is an important
antioxidant and anti-inflammatory carrier that plays a crucial role in alleviating
oxidative stress and overproduction of pro-inflammatory cytokines and chemokines in
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
lung tissues,10 while the beneficial effect of MT is associated with nuclear factor
erythroid 2-related factor 2 (Nrf2) activation.11
Nuclear factor E2-related factor 2 (Nrf2) is a major transcriptional regulator that
ensures the protection of a large number of tissues and cells from ROS-mediated
induction due to its various antioxidants and phase II detoxification enzymes,12
12activates the transcription of antioxidant genes and is also involved in the regulation
of cell proliferation and inflammatory gene expression.13 Large amounts of ROS
activate tyrosine kinases to dissociate the Nrf2: Keap1 complex, nuclear import of
Nrf2 and coordinated activation of cytoprotective gene expression.14 At the same
time, oxidative stress activates cellular NF-κB inflammatory signaling and leads to
chronic inflammation.15 Nrf2 promotes anti-inflammatory processes through
cross-talk with the NF-κB pathway.16
Considering the ubiquity of FA in urban areas due to environmental pollution, it
is important to explore effective strategies to stop the health hazards associated with
FA. Based on this, we hypothesized that MT could exert a protective effect on
FA-induced ALI through activation of Nrf2. Therefore, our study aimed to investigate
the protective role of MT in FA-induced ALI and to explore the underlying molecular
mechanisms.
2. Materials and Methods
2.1 Animals and treatment
A total of 60 famale Wistar rat weighing 130-150g (5-6 weeks old) were
purchased from Hubei Province Experimental Animal Center (Wuhan, China). All
animals were housed in a 12 h light/dark circumstance with food and water ad libitum.
All experimental procedures were performed according to the local and international
guidelines on the ethical use of animals, and all efforts were made to minimize the
number of animals used and their sufferings. Ethics approval was obtained from the
Laboratory Animal Ethics Committee of Hubei University of Science and Technology
(2019-03-021). After a week of acclimatization feeding, we randomly divided 60
female Wistar rats into six groups: Control, FA, FA+MT5mg/kg, FA+MT10mg/kg,
FA+MT20mg/kg, FA+MT10mg/kg+ML385 (APEXBIO; B8300; America), with 10
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
rats in each group. All groups, except for the Control group, were exposed to FA
(aladdin; F11941; China) 3mg/m317-18 through intranasal inhalation for 4 hours per
day for 21 days (IES-NI; China). Following this, they were treated with
intraperitoneal injections of MT (aladdin; M18674; China) at doses of 5/10/20mg/kg
19-20 for 14 days, while continuing to be exposed to FA. The Control group, on the
other hand, was injected intraperitoneally with an equal volume of 0.9% sodium
chloride solution. Refer to (Fig.1) for further detail.
2.2 Measurement of Airway hyperresponsiveness (AHR)
According to the manufacturer’s instructions of the AniRes2005 lung function
system (Bestlab, version 2.0, China), Rats were anesthetized by intraperitoneal
injection of 1% pentobarbital sodium (Urchem, China). The respiratory rate was
pre-set at 90/min, and the time ratio of expiration/inspiration was 20: 10. AHR was
assessed by the indexes of Re, Ri, and the minimum value of Cldyn. Ri and Re
R-areas, the graph area between the peak value and baseline, and the valley of Cldyn
were recorded for further analysis.
2.3 Lung Histological Assay
After ventilator testing, lung tissues were removed and fixed in 4%
paraformaldehyde (PFA, 0.1 M phosphate buffer, pH 7.4) at 4°C for 12 h. The tissues
were then embedded in paraffin wax and cut into 4-μm sections with a microtome
(RM 2165; Leica Microsystems GmbH). Sections were stained with haematoxylin
and hemoglobin (H&E), periodic acid-Schiff (PAS), and Masson's trichrome to assess
the level of inflammation or fibers in the lungs (Solarbio; G1120; G1285; G1346;
China). Briefly, the sections were deparaffinized with xylene, 100% ethanol, 90%
ethanol, and 70% ethanol, and then treated with staining solutions, stained, and sealed
with neutral resin, and then visualized with a fluorescence microscope (Olympus
IX73; Olympus). The degree of alveolar edema, intra-alveolar congestion, interstitial
edema, and intra-alveolar congestion were assessed and scored separately in this study.
Score of 0 indicates no change or very slight change, 1 indicates slight change, 2
indicates moderate change, 3 indicates severe change, and 4 indicates very severe
change. The scores of these four items were averaged to obtain the H&E staining lung
injury score.
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
2.4 Lung wet/dry (W/D) weight measurement
The body mass was first weighed, and then the anterior lobe of the right lung was
extracted to calculate the lung coefficient, which is the ratio of lung weight to body
mass. To determine the surface water content of the lung tissue, filter paper was used
to absorb the wet weight, which was then recorded. The tissue was then dried in a
constant temperature oven at 70℃ for 48 hours and weighed again to obtain the dry
weight, which was used to calculate the W/D ratio (wet weight divided by dry weight).
The lung water content was calculated to reflect the degree of pulmonary edema.
2.5 Molecular docking
The X-ray crystal structure of Nrf2 was obtained from the Protein Data Bank
(PDB ID: 1X2R https: //www.rcsb.org/). The structure of MT was downloaded from
the PubChem database (https: //www.pubchem.ncbi.nlm.nih.gov/compound) and
optimized using ChemBio3D Ultra 14.0 software (PerkinElmer Informatics). Auto
Dock Vina 1.1.2 software (Center for Computational Structural Biology) was used to
dock conformation between Nrf2 and MT. PyMOL 2.2.3 was used to visualize the
conformation.
2.6 Immunohistochemistry (IHC)
lung tissue sections were dewaxed, conducted to antigen retrieval (Beyotime
Biotech; P0083; China), treated with 3% hydrogen peroxide for 10 min, closed with
10% goat serum closure solution (Concentrated SABC-POD Rabbit IgG Kit; Boster
BiolTech; SA2002; China) for 1 h, and then incubated with primary antibody
overnight at 4°C, After the primary antibody was applied, the sample was incubated
with secondary antibodies at room temperature for 1h. The peroxidase present in the
secondary antibodies was utilized to oxidize the DAB, resulting in the formation of a
brownish-yellow precipitate with the DAB chromogenic solution. Following this, the
nuclei were stained blue with hematoxylin and observed under a fluorescence
microscope (Olympus IX73; Olympus Corporation). The fluorescence intensities
were analyzed using ImageJ 1.51j8 (National Institutes of Health). The following
primary antibodies were used: anti-Nrf2 (1: 100; proteintech; 16396-1-AP; America),
anti-HO-1 (1: 100; proteintech; 10701-1-AP; America) and anti-NF-κB (1: 100;
proteintech; 10745-1-AP; America).
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
2.7 Western blotting
The study utilized the right posterior lobe of the animal's lung, homogenized in
RIPA lysis buffer containing protease inhibitors (SEVEN Biotech; SW105;
SW107-02; China), centrifugated at 12,000 g, 4°C for 20 min. Then the supernatant
was collected, separated on SDS-PAGE, and transferred to 0.22 μm PVDF
membranes. Protein concentration was quantified using a BCA analysis kit (Abbkine;
KTD3001; America). Then the membranes were blocked with QuickBlockTM
Blocking Buffer for Western Blot (Biosharp Life Sciences; BL502A, China),
incubated with the appropriate primary antibodies overnight at 4°C. And
HRP-conjugated secondary antibodies in TBST (1: 5,000) at room temperature for 1 h.
Protein bands were visualized using ECL detection reagent (Abbkine; K22030;
America) and detected with an iBright 1500 instrument (Invitrogen; Thermo Fisher
Scientific, Inc). The grey values of bands were analyzed using ImageJ 1.51j8 software
(National Institutes of Health). β-actin was used as a loading control. The following
primary antibodies were used: anti-HO-1 (1: 1000; proteintech; 10701-1-AP;
America), anti-Nrf2 (1: 1000; Abbkine; ABP0106; America), anti-NF-κB (1: 1000;
proteintech; 10745-1-AP; America) and anti-p-NF-κB (1: 1000; Abbkine; ABP0043;
America).
2.8 Fluorescence quantitative PCR
The study utilized the right posterior lobe of rat lung, from which RNA was
extracted and purified using the Tissue Extraction RNA Kit (Dakewe Biotech;
8034111; China). Reverse transcription was performed using the All-in-one First
Strand cDNA Synthesis Kit (SEVEN Biotech; SM31-02; China) to obtain cDNA. The
cDNA obtained from the reverse transcription was used as a template and detected
using the perfectStartTM Green qpCR SuperMix kit (TransGen Biotech; AQ601-02;
China). Table 1 displays all primers used in the study. The mRNA levels were
calculated with the 2-△△Ct method and normalized to β-actin. The primer sequences
were as follows: Nrf2 5'-TTCAAGCCGATTAGAGG-3', reverse
5'-TTGCTCCTTGGACATCA-3'; HO-1: forward
5'-GGTCCTGAAGAAGATTGCG-3', reverse 5'-GATGCTCGGGAAGGTGAA-3';
Keap1: forward 5'-CGCCCTGTGCCTCTATG-3', reverse
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
5'-AGGTGCCACTCGTCTCG-3'; and β-actin: forward
5'-CGTTGACATCCGTAAAGACC-3', reverse
5’-GGAGCCAGGGCAGTAATCT-3'.
2.9 Enzyme-linked immunosorbent assay (ELISA)
After ventilator assay, the upper end of the tracheal cannula was then inserted
using a syringe, and 8 ml of saline was injected into the left lung in three separate
doses. The lavage fluid was flushed and recovered three times, and the supernatant
was centrifuged for 10 minutes at 12000 r-min-1 under 4 ℃. Finally, the levels of
TNF-α, IL-6, and IL-1β were measured using the ELISA kit (Abbkine; America)
instructions.
2.10 superoxide dismutase (SOD), glutathione (GSH), and 8-Hydroxydeoxyguanosine
(8-OHdG) analyses in the lung tissues
To detect oxidative stress indicators, some biomarkers of lipid peroxidation
including SOD (Shanghai Biyuntian Biotechnology Institute; S0101S; China), GSH
and 8-OHdG (Nanjing Jiancheng Bioengineering Institute; A061-1/H165-1-1; China)
were detected using commercial assay kits according to the manufacturer’s
instructions.
2.11 Statistical analysis
Data were expressed as mean ± standard deviation (SD) and analyzed using
Graphpad Prism 9.0. Normal distribution was assessed with the Shapiro-Wilk test,
and multiple comparisons were made using one-way ANOVA, followed by
Bonferroni test to compare data across multiple groups. Finally, we used a two-way
ANOVA with multiple comparison test to analyze the AHR results.
3. Results
3.1 MT treatment alleviates FA-induced lung function abnormalities
To assess the changes in AHR, we compared airway responses to MeCh in
different groups (Fig.2). In all experimental groups, both the expiratory and
inspiratory resistance increased with an increase in the MeCh dose, while the trough
value of Cldyn decreased. At each point, FA exposure had significant effects on Ri,
Re, and Cldyn (p < 0.05 or p < 0.01) in each treatment group. Compared with the FA
group, MT could significantly reduce the changes in lung function (p < 0.05 or p <
0.01), mainly including reduced Ri and Re and increased dynamic lung compliance.
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
This indicated that the MT could effectively reduce the changes in lung function
induced by FA.
3.2 MT treatment attenuates FA-induced ALI
In H&E staining lung tissue sections, we observed thickening of alveolar walls,
collapse of alveoli, and massive infiltration of inflammatory cells in the FA group
(Fig.3A). The W/D ratio and lung factor of lung tissue in FA group were increased,
indicating the occurrence of pulmonary edema. MT treatment reduced lung injury
scores and greatly attenuated the development of pulmonary edema (Fig.3B-D).
Masson staining demonstrated collagen fiber deposition and structural damage, and
PAS staining showed significant glycans, which indicated pathological changes such
as chronic inflammation in the lung tissue (Fig. 3E). However, treatment with MT
reduced these tissue structural abnormalities and inflammatory response induced by
FA.
3.3 MT antagonizes FA-induced ALI through the Nrf2/HO-1 pathway
A molecular docking assay was performed on the X-ray crystal structures of
Nrf2 and the ligand MT (Fig.4A). Auto Dock data showed that MT formed two
electrovalent bonds with Nrf2 at residues CLY-367 and ARG-415.The electrovalent
bond distances were measured to be 2.2 ng strom between Nrf2 CLY-367 and MT,
and 2.3 ng strom between Nrf2 ARG-415 and MT. And the binding affinity was
-7.6 kcal/mol. It indicates that Nrf2 has a higher affinity for MT. To investigate the
protective mechanism of MT against FA-induced ALI, the level and localization of
Nrf2/HO-1 were analyzed by immunohistochemical analysis. The expression level of
Nrf2/HO-1 in the lung tissue of rats in FA group was lower than that in the control
group, but MT could promote the entry of Nrf2 into the nucleus and up-regulate the
expression of Nrf2, suggesting that the protective effect of MT on FA-induced ALI
might be related to the up-regulation of Nrf2 (Fig.4B-C). In addition, we
demonstrated the protective effect of Nrf2 against FA-induced ALI with Nrf2
inhibitor ML385, which significantly reversed FA-induced oxidative stress in lung
tissue. These findings suggest that Nrf2 plays an important role in the development of
FA-induced ALI, and that MT may ameliorate FA-induced ALI by activating Nrf2,
thereby reducing oxidative stress. The changes of Nrf2/HO-1 expression levels in the
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
Results
of Western blot and qPCR were consistent with the results of
immunohistochemistry (Figure 4D-H), and the mRNA expression level of keap1, the
downstream molecule of Nrf2/HO-1, also showed significant changes. (Fig.4I).
3.4 MT alleviates inflammation and oxidative stress through Nrf2
Western blot analysis showed that the expression level of p-NF-κB in lung
tissue of the FA group was higher than that of the control group, which was
significantly reduced by MT treatment; however, Nrf2 inhibitor ML385 could reverse
the effect of MT (Fig.5A-B). In addition, we also found the changes of inflammatory
factors TNF-α, IL-6, IL-1β and oxidation indicators GSH, SOD, 8-OHDG in lung
tissue. FA resulted in the decrease of TNF-α, IL-6, and IL-1β products, as well as the
decrease of GSH content and SOD activity, and the increase of 8-OHDG content,
which is a marker of DNA oxidative damage. Levels of inflammation and oxidative
stress were significantly reduced when MT was administered, and similarly the Nrf2
inhibitor ML385 reversed the effects of M (Fig.5C-H). These results suggest that MT
alleviates FA-induced lung tissue damage by alleviating inflammatory response and
oxidative stress through Nrf2.
3.5 Antagonistic effect of ML385 on the protective effect of MT against acute lung
injury
AHR results showed that lung function was improved in the MT group, but
decreased after Nrf2 inhibitor administration, which was close to the level of the FA
group, suggesting that inhibiting Nrf2 pathway may antagonize the improvement
effect of MT on FA-induced lung function abnormalities (Fig.6A). HE staining of
lung tissue showed that the degree of lung tissue damage in the Nrf2 inhibitor group
was similar to that in the FA group, indicating that Nrf2 inhibitor ML385 could
antagonize the protective effect of MT. In addition, lung tissue score, W/D ratio, lung
coefficient, Masson and PAS staining further confirmed that MT alleviated
FA-induced ALI by activating the Nrf2 pathway (Fig.6B-F).
4. Discussion
ALI/ARDS is an important clinical syndrome associated with high morbidity and
mortality, especially in critically ill patients.21 The pathological manifestations of ALI
primarily involve acute inflammatory responses and dysfunction of alveolar epithelial
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
membrane due to tissue damage.22 Moreover, cytokine mediated inflammatory
processes aggravate the damage of epithelial and endothelial cells in the pathogenesis
of ALI.23 FA is a prevalent environmental pollutant found in various sources such as
wood products, plastics, synthetic fibers, insulation materials, upholstery, paints,
varnishes, household cleaning products, and cigarettes.24 Exposure to FA exacerbates
the inflammatory response, which is closely associated with its potential mechanism
for inducing lung injury. Furthermore, FA exposure can enhance the growth of indoor
bacterial communities, and long-term exposure may lead to the development of
bacterial communities that pose a high risk to human health.25 Although FA is known
to cause lung damage, the specific molecular mechanisms underlying this effect
remain largely unknown. Therefore, multifaceted validation of new drugs for
antagonizing FA-induced ALI is essential.
MT has attracted attention for its various biological activities, such as its
anti-inflammatory and antioxidant properties.27 However, the potential of MT in the
treatment of FA-induced ALI has not been clearly defined. To date, studies have
shown that MT has been investigated as a potential treatment for various cross-organ
systemic pathological conditions27 and that it is also effective in patients infected with
neocoronary pneumonia by reducing vascular permeability, anxiety, sedative use and
improving sleep quality.28 And MT is also a very effective scavenger of superoxide
and hydroxyl radicals.29 Our study found that this compound also blocks the
production of pro-oxidant enzymes by indirectly inhibiting NF-κB. Another indirect
antioxidant effect of MT is mediated by Nrf2 transcription factor activation. For
example, MT can attenuate diabetes-related restenosis in rats by activating Nrf2
signaling.30 Indeed, MT also exhibits critical potential in various respiratory diseases
because of the abundance of high-affinity MT receptors captured in lung tissue.31
In our study, we discovered that MT played a crucial role in mitigating
FA-induced ALI. Through a series of experiments, we observed that MT significantly
enhanced lung function. Specifically, it decreased inspiratory and expiratory
resistance while increasing lung compliance, thereby reducing airway
hyperresponsiveness. This suggests that MT has a positive impact on respiratory
function. Additionally, we assessed the structure and function of lung tissue using HE
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
staining, Masson staining, PAS staining, lung injury score, W/D ratio, and lung
coefficient. These results indicated that MT reduced inflammatory cell infiltration and
collagen fiber proliferation in lung tissue, leading to improved alveolar structure and
alleviation of lung injury. Notably, MT decreased the lung injury score and W/D ratio
while improving the lung coefficient, indicating its ability to protect the structure and
function of lung tissue.
Several studies have shown that Nrf2 is a signaling coordinator that attenuates
environmental particulate matter PM2.5-induced lung tissue damage by suppressing
inflammation and oxidative stress.32 Under normal conditions, Nrf2 binds to
Kerch-like ECH-associated protein 1 (Keap1), and when the organism is under
oxidative stress, Nrf2 segregates from its negative regulator cytoskeleton-associated
protein Kelch-like ECH-associated protein 1 (Keap1) and translocates to the nucleus,
where it further promotes transcription of downstream antioxidant genes such as
HO-1 upon entry.33 To further investigate the role of Nrf2 in MT treatment of
FA-induced ALI, we used Nrf2 inhibitor ML385 as an antagonist group. Through
IHC, WB and qPCR analysis, we found that ML385 significantly inhibited the
increase of Nrf2/HO-1 expression in lung tissue after MT treatment. These results
suggest that Nrf2 plays a crucial role in alleviating FA-induced ALI after MT
treatment, and provide a valuable reference for further exploring the therapeutic
potential of Nrf2 in respiratory diseases.
NF-κB is a nuclear transcription factor that is key signaling molecule of the
classical inflammatory pathway that regulates the expression of several genes in the
inflammatory response.34 Nrf2/Keap1/HO-1 signaling negatively regulates NF-κB
transmission in oxidative stress and inflammatory responses, initiating
NF-κB-dependent transcriptional pathways that rapidly induce the secretion of
inflammatory factors.35 Upon activation, NF-κB translocates to the nucleus and binds
to specific DNA sequences, leading to the transcriptional expression of inflammatory
factors such as IL-1β, TNF-α, and IL-6. This activation also triggers a positive
feedback mechanism, further amplifying the inflammatory response. NF-κB plays a
crucial role in the body's immune response and disease progression. It is important to
note that the inflammatory response can induce oxidative stress, which further
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
exacerbates inflammation, creating a vicious cycle.36 Our study showed that MT
reduced expression of inflammatory and increases level of antioxidant in lung tissue,
while Nrf2 inhibitor ML385 can reverse this effect, suggesting that MT regulated
inflammation and oxidative stress by activating the Nrf2 pathway, thereby alleviating
FA-induced ALI.
Studies have shown that FA leads to inflammation closely associated with
oxidative stress and the development and progression of ALI. MT, a novel agonist of
Nrf2, can resist FA-induced inflammation and oxidative stress, thereby alleviating
acute lung injury (Fig.7). This study discloses for the first time that MT
supplementation can prevent the deleterious effects of FA on lung tissue, and it is
expected that MT could be a possible candidate for the prevention of
pollution-induced lung injury.
Figure Notes
Fig.1 Schematic diagram of the experimental procedures
Fig.2 MT treatment alleviates FA-induced lung function abnormalities
(A) R-area of Ri, (B) R-area of Re, and (C) peak value of Cldyn at different doses of
MeCh Animal groups (in all panels): n = 3 rat per group. (*: p < 0.05, **: p < 0.01,
compared with the FA group; ##: p < 0.01, compared with the control group).
Fig.3 MT treatment attenuates FA-induced ALI
(A) Representative H&E staining images of each group of lung tissue sections. Scale
bar = 50μm. (B) Quantitative analysis of inflammation score for the H&E staining in
each group. (C) Lung wet/dry (W/D) weight ratio. (D) Lung coefficient measurement.
(E) Representative Masoon/PAS-stained images of lung tissue sections from various
groups. Scale bar = 50μm.
Animal groups (in all panels): n = 3 rat per group. (*: p < 0.05, **: p < 0.01,
compared with the FA group; #: p < 0.05, ##: p < 0.01, compared with the control
group).
Fig.4 MT antagonizes FA-induced ALI through the Nrf2/HO-1 pathway
(A) The docking results of MT with Nrf2. The modelled 3D structure of Nrf2
docked with MT. he enlarged view of binding site in box. Nrf2 protein was shown in
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
color cyan. MT was colored green. The interaction residues showed as color red,
bonds showed as yellow dotted lines, and bond lengths were presented as numbers.
(B-C) Immunohistochemistry-based images of Nrf2/HO-1 in the lung tissues. Scale
bar = 50μm. (D-F) Western blot analysis and quantification of relative grayscale
values of Nrf2/HO-1 expression levels for each group. (G) Nrf2 qPCR results. (H)
HO-1 qPCR results; (I) Keap1 qPCR results. Animal groups (in all panels): n = 3 rat
per group. (*: p < 0.05, **: p < 0.01, compared with the FA group; #: p < 0.05, ##: p
< 0.01, compared with the control group. &: p < 0.05).
Fig.5 MT alleviates inflammation and oxidative stress through Nrf2
(A-B) Western blot analysis and quantification of relative grayscale values of
NFĸB/p-NFĸB expression levels for each group. (C-E) TNF-α, IL-1β and IL-6
concentrations in the BALF. (F-H) Analysis of SOD, GSH and 8-OHdG levels in rat
lung tissue by kit. Animal groups (in all panels): n = 3 rat per group. (*: p < 0.05, **:
p < 0.01, compared with the FA group; #: p < 0.05, ##: p < 0.01, compared with the
control group. &: p < 0.05, &&: p < 0.01, compared with the FA+MT10mg/kg
group).
Fig.6 Antagonistic effect of ML385 on the protective effect of MT against acute lung
injury
(A) Representative H&E staining images of each group of lung tissue sections. Scale
bar = 50μm. (B) Quantitative analysis of inflammation score for the H&E staining in
each group. (C) Lung wet/dry (W/D) weight ratio. (D) Lung coefficient measurement.
(E) Representative Masoon/PAS-stained images of lung tissue sections from various
groups. Scale bar = 50μm. (F) R-area of Ri, (G) R-area of Re and (H) peak value of
Cldyn (in all panels): n = 3 rat per group. (&&: p < 0.01, compared with the
FA+MT0mg/kg group).
Fig.7 Schematic diagram of the potential mechanisms of MT treatment for acute lung
injury caused by FA.
Funding:National Natural Science Foundation of China (81902937), Hubei College
of Science and Technology, School of Ophthalmology and Stomatology (2020WG06),
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
Hubei College of Science and Technology, School of Ophthalmology and
Stomatology (2021WG10).
References
1. Liu R, Luo X, Li J, Lei Y, Zeng F, Huang X, Yang F. Melatonin: A window into
the organ-protective effects of sepsis. J Biomedicine & Pharmacotherapy, 2022,
154, 113556.
2. Störmann P, Becker N, Vollrath J T, Köhler K, Janicova A, Wutzler S, Relja B.
Early local inhibition of club cell protein 16 following chest trauma reduces late
sepsis-induced acute lung injury. J Journal of Clinical Medicine, 2019, 8 (6),
896.
3. Lai W Y, Wang J W, Huang B T, Lin E P Y, Yang P C. A novel TNF-α-targeting
aptamer for TNF-α-mediated acute lung injury and acute liver failure. J
Theranostics, 2019, 9 (6), 1741.
4. Zhang X, Zhao Y, Song J, Yang X, Zhang J, Zhang Y, Li R. Differential health
effects of constant versus intermittent exposure to formaldehyde in mice:
implications for building ventilation strategies. J Environmental science &
technology, 2018, 52 (3), 1551-1560.
5. Ding Y, Cui Y, Zhou Z, Hou Y, Pang X, Nie H. Lipopolysaccharide inhibits alpha
epithelial sodium channel expression via miR-124-5p in alveolar type 2 epithelial
cells. J BioMed Research International, 2020, 2020.
6. Cui Y, Li H, Wu S, Zhao R, Du D, Ding Y, Ji H L. Formaldehyde impairs
transepithelial sodium transport. J Scientific reports, 2016, 6 (1), 35857.
7. Chow C W, Herrera Abreu M T, Suzuki T, Downey G P. Oxidative stress and acute
lung injury. J American journal of respiratory cell and molecular biology, 2003,
29 (4), 427-431.
8. Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the
role of melatonin. J Nutrients, 2021, 13 (10), 3480.
9. Wang W, Gao J. Effects of melatonin on protecting against lung injury. J
Experimental and therapeutic medicine, 2021, 21 (3), 1-1.
10. Kang J Y, Xu M M, Sun Y, Ding Z X, Wei Y Y, Zhang D W, Fei G H. Melatonin
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3
GSDMD pathway via activating Nrf2/HO-1 signaling axis. J International
Immunopharmacology, 2022, 109, 108782.
11. Arioz B I, Tastan B, Tarakcioglu E, Tufekci K U, Olcum M, Ersoy N, Genc S.
Melatonin attenuates LPS-induced acute depressive-like behaviors and
microglial NLRP3 inflammasome activation through the SIRT1/Nrf2 pathway. J
Frontiers in immunology, 2019, 10: 455021.
12. Gong Y, Yang Y. Activation of Nrf2/AREs-mediated antioxidant signalling, and
suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic
strategy for hepatic fibrosis—a review. J Life Sciences, 2020, 256, 117909.
13. He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond. J
International journal of molecular sciences, 2020, 21 (13), 4777.
14. Sajadimajd S, Khazaei M. Oxidative stress and cancer: the role of Nrf2. J Current
cancer drug targets, 2018, 18 (6), 538-557.
15. Luo J G, Zhao X L, Xu W C, Zhao X J, Wang J N, Lin X W, Fu Z J. Activation of
spinal NF‐κB/p65 contributes to peripheral inflammation and hyperalgesia in rat
adjuvant‐induced arthritis. J Arthritis & Rheumatology, 2014, 66 (4), 896-906.
16. Cao Y, Fan D, Yin Y. Pain mechanism in rheumatoid arthritis: from cytokines to
central sensitization. J Mediators of Inflammation, 2020, 2020.
17. Zhao Y, Magaña L C, Cui H, Huang J, McHale C M, Yang X, Zhang L.
Formaldehyde-induced hematopoietic stem and progenitor cell toxicity in mouse
lung and nose. J Archives of toxicology, 2021, 95, 693-701.
18. Yang Y Q, Ge P, Lv M Q, Yu P F, Liu Z G, Zhang J, Zhou D X.
Rno_circRNA_008646 regulates formaldehyde induced lung injury through
Rno-miR-224 mediated FOXI1/CFTR axis. J Ecotoxicology and Environmental
Safety, 2022, 243, 113999.
19. Wang M L, Wei C H, Wang W D, Wang J S, Zhang J, Wang J J. Melatonin
attenuates lung ischaemia–reperfusion injury via inhibition of oxidative stress
and inflammation. J Interactive CardioVascular and Thoracic Surgery, 2018, 26
(5), 761-767.
20. Yang B, Ni Y F, Wang W C, Du H Y, Zhang H, Zhang L, Jiang T. Melatonin
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
attenuates intestinal ischemia–reperfusion-induced lung injury in rats by
upregulating N-myc downstream-regulated gene 2. J journal of surgical
research, 2015, 194 (1), 273-280.
21. Kellner M, Noonepalle S, Lu Q, Srivastava A, Zemskov E, Black S M. ROS
signaling in the pathogenesis of acute lung injury (ALI) and acute respiratory
distress syndrome (ARDS). J Pulmonary vasculature redox signaling in health
and disease, 2017, 105-137.
22. Niethamer T K, Stabler C T, Leach J P, Zepp J A, Morley M P, Babu A, Morrisey
E E. Defining the role of pulmonary endothelial cell heterogeneity in the
response to acute lung injury. J Elife, 2020, 9, e53072.
23. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Hara
N. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung
injury in mice by a caspase inhibitor. J The American journal of pathology, 2000,
157 (2), 597-603.
24. Shao Y, Wang Y, Zhao R, Chen J, Zhang F, Linhardt R J, Zhong W.
Biotechnology progress for removal of indoor gaseous formaldehyde. J Applied
microbiology and biotechnology, 2020, 104, 3715-3727.
25. Guo J, Xiong Y, Kang T, Zhu H, Yang Q, Qin C. Effect of formaldehyde
exposure on bacterial communities in simulating indoor environments. J
Scientific Reports, 2021, 11 (1), 20575.
26. Muñoz Jurado A, Escribano B M, Caballero Villarraso J, Galván A, Agüera E,
Santamaría A, Túnez I. Melatonin and multiple sclerosis: antioxidant,
anti-inflammatory and immunomodulator mechanism of action. J
Inflammopharmacology, 2022, 30 (5), 1569-1596.
27. Liu C, Xiao K, Xie L. Advances in the use of exosomes for the treatment of
ALI/ARDS. J Frontiers in Immunology, 2022, 4449.
28. Chitimus D M, Popescu M R, Voiculescu S E, Panaitescu A M, Pavel B, Zagrean
L, Zagrean A M. Melatonin’s impact on antioxidative and anti-inflammatory
reprogramming in homeostasis and disease. J Biomolecules, 2020,10 (9), 1211.
29. Kruk J, Aboul-Enein B H, Duchnik E. Exercise-induced oxidative stress and
melatonin supplementation: current evidence. J The Journal of Physiological
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
Sciences, 2021, 71, 1-19.
30. Wang X, Li T, Ma B, Zhao Z, Ni L, Zhang R, Liu C. Melatonin attenuates
restenosis after vascular injury in diabetic rats through activation of the Nrf2
signaling pathway. J Biochemical and Biophysical Research
Communications, 2021, 548, 127-133.
31. Mazzoccoli G, Kvetnoy I, Mironova E, Yablonskiy P, Sokolovich E, Krylova J,
Polyakova V. The melatonergic pathway and its interactions in modulating
respiratory system disorders. J Biomedicine & Pharmacotherapy, 2021, 137,
111397.
32. Guohua F, Tieyuan Z, Xinping M, Juan X. Melatonin protects against PM2.
5-induced lung injury by inhibiting ferroptosis of lung epithelial cells in a
Nrf2-dependent manner. J Ecotoxicology and Environmental Safety, 2021, 223,
112588.
33. Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2
pathway. J Molecular and cellular biology, 2020, 40 (13), e00099-20.
34. Poma P. NF-κB and Disease. J Int J Mol Sci.2020, 21 (23): 9181.
35. Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C. Activation of Nrf2/HO-1
signaling: An important molecular mechanism of herbal medicine in the
treatment of atherosclerosis via the protection of vascular endothelial cells from
oxidative stress. J Journal of advanced research, 2021, 34, 43-63.
36. Li J, Deng S H, Li J, Li L, Zhang F, Zou Y, Xu Y. Obacunone alleviates
ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating
Nrf2 dependent antioxidant responses. J Cellular & Molecular Biology
Letters, 2022, 27 (1), 1-20.
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted December 18, 2024. ; https://doi.org/10.1101/2024.12.17.629008doi: bioRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.